Optimization of the magnetic labeling of human neural stem cells and MRI visualization in the hemiparkinsonian rat brain

Journal of Nanobiotechnology

Volumn 13, Issue 1, 2015, Pages

  Ramos Gómez, Milagros ^a,b   Seiz, Emma G ^c   Martínez Serrano, Alberto ^c  

^a UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Cell tracking; Magnetic nanoparticles; Magnetic resonance imaging; Neural stem cell

Indexed keywords

CELLS; CYTOLOGY; MAGNETIC RESONANCE IMAGING; MAGNETISM; NANOMAGNETICS; NANOPARTICLES; RATS; RESONANCE; STEM CELLS;

CELL DIFFERENTIATION; CELL TRACKING; LONGITUDINAL STUDY; MAGNETIC NANO-PARTICLES; NEURAL STEM CELL; PARKINSON'S DISEASE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; TRANSFECTION AGENTS;

MOLECULAR BIOLOGY;

MAGNETIC NANOPARTICLE; DEXTRAN; MAGNETITE NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL STRUCTURE; CELL TRACKING; CELL VIABILITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MICROGLIA; NEURAL STEM CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; RAT; ANIMAL; BRAIN; CELL CULTURE; CELL SURVIVAL; CELL TRANSPLANTATION; CHEMISTRY; CYTOLOGY; GENETIC TRANSFECTION; PARKINSON DISEASE; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SPRAGUE DAWLEY RAT; TRANSPLANTATION;

RATTUS;

ANIMALS; BRAIN; CELL SURVIVAL; CELL TRACKING; CELL TRANSPLANTATION; CELLS, CULTURED; DEXTRANS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; NEURAL STEM CELLS; PARKINSON DISEASE; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; TRANSFECTION;

EID: 84928605641     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/s12951-015-0078-4     Document Type: Article

References (58)

1. Lindvall O, Bjorklund A. Cell therapeutics in Parkinson's disease. Neurotherap. 2011;8:539-48.
2. Lindvall O, Kokaia Z. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol Sci. 2009;30:260-7.
3. Politis M, Lindvall O. Clinical application of stem cell therapy in Parkinson's disease. BMC Med. 2012;4:10-1.
4. Lindvall O, Kokaia Z. Stem cells in human neurodegenerative disorders-time for clinical translation? J Clin Invest. 2010;120:29-40.
5. Ramos-Moreno T, Castillo CG, Martínez-Serrano A. Long term behavioral effects of functional dopaminergic neurons generated from human neural stem cells in the rat 6-OH-DA Parkinson's disease model. Effects of the forced expression of BCL-X(L). Behav Brain Res. 2012;232:225-32.
6. Krabbe C, Bak ST, Jensen P, von Linstow C, Martínez-Serrano A, Hansen C, et al. Influence of oxygen tension on dopaminergic differentiation of human fetal stem cells of midbrain and forebrain origin. PLoS One. 2014;9:e96465.
7. Seiz EG, Ramos-Gómez M, Courtois ET, Tønnesen J, Kokaia M, Liste Noya I, et al. A Human midbrain precursors activate the expected developmental genetic program and differentiate long-term to functional A9 dopamine neurons in vitro. Enhancement by Bcl-X(L). Exp Cell Res. 2012;318:2446-59.
8. Villa A, Liste I, Courtois ET, Seiz EG, Ramos M, Meyer M, et al. Generation and properties of a new human ventral mesencephalic neural stem cell line. Exp Cell Res. 2009;315:1860-74.
9. Courtois ET, Castillo CG, Seiz EG, Ramos M, Bueno C, Liste I, et al. In vitro and in vivo enhanced generation of human A9 dopamine neurons from neural stem cells by Bcl-XL. J Biol Chem. 2010;285:9881-97.
10. Ramos-Moreno T, Lendinez JG, Pino-Barrio MJ, Del Arco A, Martinez-Serrano A. Clonal human fetal ventral mesencephalic dopaminergic neuron precursors for cell therapy research. PLoS One. 2012;7:e52714.
11. Chen A, Siow B, Blamire AM, Lako M, Clowry GJ. Transplantation of magnetically labeled mesenchymal stem cells in a model of perinatal brain injury. Stem Cell Res. 2010;5:255-66.
12. Cohen ME, Muja N, Fainstein N, Bulte JW, Ben-Hur T. Conserved fate and function of ferumoxides-labeled neural precursor cells in vitro and in vivo. J Neurosci Res. 2010;88:936-44.
13. Berman SC, Galpoththawela C, Gilad AA, Bulte JW, Walczak P. Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells. Magn Reson Med. 2011;65:564-74.
14. Focke A, Schwarz S, Foerschler A, Scheibe J, Milosevic J, Zimmer C, et al. Labeling of human neural precursor cells using ferromagnetic nanoparticles. Magn Reson Med. 2008;60:1321-8.
15. Muja N, Cohen ME, Zhang J, Kim H, Gilad AA, Walczak P, et al. Neural precursors exhibit distinctly different patterns of cell migration upon transplantation during either the acute or chronic phase of EAE: a serial MR imaging study. Magn Reson Med. 2011;65:1738-49.
16. Swijnenburg R, van der Bogt KE, Sheikh AY, Cao F, Wu JC. Clinical hurdles for the transplantation of cardiomyocytes derived from human embryomic stem cells: role of molecular imaging. Curr Opin Biotech. 2007;18:38-45.
17. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol. 2000;18:410-4.
18. Syková E, Jendelová P. Magnetic resonance tracking of implanted adult and embryonic stem cells in injured brain and spinal cord. Ann NY Acad Sci. 2005;1049:146-60.
19. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, et al. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood. 2004;104:1217-23.
20. Sipe JC, Filippi M, Martino G, Furlan R, Rocca MA, Rovaris M, et al. Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents. Magn Reson Imaging. 1999;17:1521-3.
21. Bulte JW, Laughlin PG, Jordan EK, Tran VA, Vymazal J, Frank JA. Tagging of T cells with superparamagnetic iron oxide: uptake kinetics and relaxometry. Acad Radiol. 1996;3 Suppl 2:301-3.
22. Dodd SJ, Williams M, Suhan JP, Williams DS, Koretsky AP, Ho C. Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys J. 1999;76:103-9.
23. Neri M, Maderna C, Cavazzin C, Deidda-Vigoriti V, Politi LS. Efficient in vitro labeling of human neural precursor cells with superparamagnetic iron oxide particles: relevance for in vivo cell tracking. Stem Cells. 2008;26:505-16.
24. Martínez-Serrano A, Castillo CG, Courtois ET, García-García E, Liste I. Modulation of the generation of dopaminergic neurons from human neural stem cells by Bcl-X(L): mechanisms of action. Vitam Horm. 2011;87:175-205.
25. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991;139:271-9.
26. Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, Read EJ, et al. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed. 2005;18:553-9.
27. Pawelczyk E, Arbab AS, Pandit S, Hu E, Frank JA. Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging. NMR Biomed. 2006;19:581-92.
28. Panizzo RA, Kyrtatos PG, Price AN, Gadian DG, Ferretti P, Lythgoe MF. In vivo magnetic resonance imaging of endogenous neuroblasts labeled with a ferumoxide-polycation complex. Neuroimage. 2009;44:1239-46.
29. Kedziorek DA, Muja N, Walczak P, Ruiz-Cabello J, Gilad AA, Jie CC, et al. Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles. Magn Reson Med. 2010;63:1031-43.
30. Gao J, Gu H, Xu B. Multifunctional Magnetic Nanoparticles: Design, Synthesis, and Biomedical Applications. Acc Chem Res. 2009;42:1097-107.
31. Winkler C, Kirik D, Bjorklund A. Cell transplantation in Parkinson's disease: how can we make it work. Trends Neurosci. 2005;28:86-92.
32. Brundin BP, Strecker RE, Widner H, Clarke DJ, Nilsson OG, Astedt B, et al. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour and dopamine release. Exp Brain Res. 1988;70:192-208.
33. Geeta R, Ramnath RL, Rao HS, Chandra V. One year survival and significant reversal of motor deficits in parkinsonian rats transplanted with hESC derived dopaminergic neurons. Biochem Biophys Res Commun. 2008;373:258-64.
34. Weissleder R, Cheng HC, Bogdanova A, Bogdanov Jr A. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging. 1997;7:258-63.
35. Cromer Berman SM, Walczak P, Bulte JW. Tracking stem cells using magnetic nanoparticles. Rev Nanomed Nanobiotechnol. 2011;3:343-55.
36. Jasmin, Torres AL, Jelicks L, de Carvalho AC, Spray DC, Mendez-Otero R. Labeling stem cells with superparamagnetic iron oxide nanoparticles: analysis of the labeling efficacy by microscopy and magnetic resonance imaging. Methods Mol Biol. 2012;906:239-52.
37. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed. 2004;17:513-7.
38. Thu MS, Najbauer J, Kendall Q, Harutyunyan I, Sangalang N, Gutova M, et al. Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model. PLoS One. 2009;4:e7218.
39. Hoehn M, Kustermann E, Blunk J, Wiedermann D, Trapp T, Wecker S. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental sroke in rat. Proc Natl Acad Sci U S A. 2002;99:16267-72.
40. Yano S, Kuroda S, Shichinohe H, Hida K, Iwasaki Y. Do bone marrow stromal cells proliferate after transplantation into mice cerebral infarct?-a double labeling study. Brain Res. 2005;1065:60-7.
41. Novotna B, Jendelova P, Kapcalova M, Rossner Jr P, Turnovcova K, Bagryantseva Y, et al. Oxidative damage to biological macromolecules in human bone marrow mesenchymal stromal cells labeled with various types of iron oxide nanoparticles. Toxicol Lett. 2012;210:53-63.
42. Sun R, Dittrich J, Le-Huu M. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: A comparison. Invest Radiol. 2005;40:504-13.
43. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Bulte JW, Frank JA. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation. 2003;76:1123-30.
44. Bulte JW, Douglas T, Witwer B, Zhang SC, Strable E, Miller BP, et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol. 2001;19:1141-7.
45. Amemori T, Romanyuk N, Jendelova P, Herynek V, Turnovcova K, Prochazka P, et al. Human conditionally immortalized neural stem cells improve locomotor function after spinal cord injury in the rat. Stem Cell Res Ther. 2013;4:68-72.
46. Park KI, Liu S, Flax JD, Nissim S, Stieg PE, Snyder EY. Transplantation of neural progenitor and stem cells: Developmental insights may suggest new therapies for spinal cord and other CNS dysfunction. J Neurotrauma. 1999;16:675-87.
47. Guzman R, Uchida N, Bliss TM, He D, Christopherson KK, Stellwagen D, et al. Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci U S A. 2007;104:10211-6.
48. Thu MS, Bryant LH, Coppola T, Jordan EK, Budde MD, Lewis BK, et al. Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat Med. 2012;18:463-7.
49. Farrell E, Wielopolski P, Pavljasevic P, van Tiel S, Jahr H, Verhaar J, et al. Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. Biochem Biophys Res Commun. 2008;369:1076-81.
50. Crabbe A, Vandeputte C, Dresselaers T, Sacido AA, Verdugo JM, Eyckmans J, et al. Effects of MRI contrast agents on the stem cell phenotype. Cell Transplant. 2010;19:919-36.
51. Söderstjerna E, Johansson F, Klefbohm B, Englund Johansson U. Gold- and silver nanoparticles affect the growth characteristics of human embryonic neural precursor cells. PLoS One. 2013;8:e58211.
52. Rubio FJ, Bueno C, Villa A, Navarro B, Martínez-Serrano A. Genetically perpetuated human neural stem cells engraft and differentiate into the adult mammalian brain. Mol Cell Neurosci. 2000;16:1-13.
53. Grealish S, Diguet E, Kirkeby A, Mattsson B, Heuer A, Bramoulle Y, et al. Human ESC-Derived Dopamine Neurons Show Similar Preclinical Efficacy and Potency to Fetal Neurons when Grafted in a Rat Model of Parkinson's Disease. Cell Stem Cell. 2014;15:653-65.
54. Piccini P, Lindvall O, Bjorklund A, Brundin P, Hagell P, Ceravolo R, et al. Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol. 2000;48:689-95.
55. Nicholas CR, Chen J, Tang Y, Southwell DG, Chalmers N, Vogt D, et al. Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development. Cell Stem Cell. 2013;12:573-86.
56. Arbab AS, Pandit SD, Anderson SA, Yocum GT, Bur M, Frenkel V, et al. Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumor angiogenesis. Stem Cells. 2006;24:671-8.
57. Urdzikova L, Jendelova P, Glogarova K, Burian M, Hajek M, Sykova E. Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma. 2006;23:1379-91.
58. Pawelczyk E, Arbab AS, Chaudhry A, Balakumaran A, Robey PG. In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: implications for cellular therapy. Stem Cells. 2008;26:1366-75.